SCHEMBL29587382

SCHEMBL29587382

Cc1ccc2cccc(S(=O)(=O)NC(=O)c3cc4c(F)cc(C5CC5)cc4o3)c2n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.40
POLB P06746 5/20 0.40
SMN1; SMN2 Q16637 5/20 0.40
TSHR P16473 3/20 0.40
TP53 P04637 3/20 0.40
USP2 O75604 2/20 0.40
LMNA P02545 1/20 0.38
NFKBIA P25963 2/20 0.35
RELA Q04206 2/20 0.35
SLC40A1 Q9NP59 1/20 0.35
ALDH1A1 P00352 2/20 0.34
KDM4E B2RXH2 2/20 0.34
THRB P10828 2/20 0.34
SLC16A3 O15427 1/20 0.33
NPC1 O15118 1/20 0.33
NR1I2 O75469 1/20 0.33
HPGD P15428 1/20 0.33
AHR P35869 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24314295 1.00 HSD17B10 (0.40) HSD17B10POLBSMN1; SMN2TSHRTP53
SCHEMBL29588270 0.89 HSD17B10 (0.39) HSD17B10POLBSMN1; SMN2TSHRTP53
SCHEMBL29587778 0.88 HSD17B10 (0.39) HSD17B10POLBSMN1; SMN2TSHRTP53
SCHEMBL24314312 0.88 HSD17B10 (0.39) HSD17B10POLBSMN1; SMN2TSHRTP53
SCHEMBL24313957 0.87 HSD17B10 (0.37) HSD17B10POLBSMN1; SMN2TSHRTP53
SCHEMBL29587405 0.87 HSD17B10 (0.37) HSD17B10POLBSMN1; SMN2TSHRTP53
SCHEMBL22587857 0.86 POLB (0.41) HSD17B10POLBSMN1; SMN2TSHRTP53
SCHEMBL22588218 0.84 POLB (0.39) HSD17B10POLBSMN1; SMN2TSHRTP53
SCHEMBL24334348 0.84 POLB (0.39) HSD17B10POLBSMN1; SMN2TSHRTP53
SCHEMBL29469614 0.84 POLB (0.39) HSD17B10POLBSMN1; SMN2TSHRTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229045-B1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER BROAD INST INC (US) 2025-11-12 EP claimed
EP-4229045-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute Inc. (US) 2023-08-23 EP claimed
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO claimed
EP-4229045-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute Inc. (US) 2023-08-23 EP disclosed
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed